ASX - By Stock
|
PTX |
Re:
updated chart
|
|
AMS71
|
3.2K |
1.2M |
5 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
3.2K
|
1.2M
|
5
|
|
ASX - By Stock
|
PTX |
Re:
Today's Briefing session thoughts?
|
|
AMS71
|
5 |
2.1K |
14 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
5
|
2.1K
|
14
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
AMS71
|
3.2K |
1.2M |
5 |
01/11/22 |
01/11/22 |
ASX - By Stock
|
3.2K
|
1.2M
|
5
|
|
ASX - By Stock
|
PTX |
Re:
Ann: SPP Results and Placement
|
|
AMS71
|
50 |
21K |
5 |
12/10/22 |
12/10/22 |
ASX - By Stock
|
50
|
21K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
AMS71
|
1.6K |
675K |
5 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
1.6K
|
675K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Trading Halt
|
|
AMS71
|
30 |
12K |
13 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
30
|
12K
|
13
|
|
ASX - By Stock
|
PTX |
Re:
updated chart
|
|
AMS71
|
3.2K |
1.2M |
14 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
3.2K
|
1.2M
|
14
|
|
ASX - By Stock
|
PTX |
Re:
PTX Media related
|
|
AMS71
|
1.6K |
675K |
2 |
25/08/21 |
25/08/21 |
ASX - By Stock
|
1.6K
|
675K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
oppies
|
|
AMS71
|
314 |
96K |
5 |
09/08/21 |
09/08/21 |
ASX - By Stock
|
314
|
96K
|
5
|
|
ASX - By Stock
|
PTX |
Re:
sp should be 5x imho
|
|
AMS71
|
1.0K |
398K |
1 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
1.0K
|
398K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
sp should be 5x imho
|
|
AMS71
|
1.0K |
398K |
3 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
1.0K
|
398K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
sp should be 5x imho
|
|
AMS71
|
1.0K |
398K |
3 |
28/05/21 |
28/05/21 |
ASX - By Stock
|
1.0K
|
398K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Capital Structure Update - Expiry of Unlisted Options
|
|
AMS71
|
4 |
2.1K |
2 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
4
|
2.1K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 AML Trial Progresses to Higher Dose
|
|
AMS71
|
38 |
15K |
2 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
38
|
15K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 AML Trial Progresses to Higher Dose
|
|
AMS71
|
38 |
15K |
6 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
38
|
15K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 AML Trial Progresses to Higher Dose
|
|
AMS71
|
38 |
15K |
15 |
25/04/21 |
25/04/21 |
ASX - By Stock
|
38
|
15K
|
15
|
|
ASX - By Stock
|
PTX |
Re:
CAR - T Treatment Therapy
|
|
AMS71
|
117 |
43K |
7 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
117
|
43K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Amgen applies for a Kras G12C inhibitor approval with FDA
|
|
AMS71
|
7 |
3.4K |
23 |
21/12/20 |
21/12/20 |
ASX - By Stock
|
7
|
3.4K
|
23
|
|
ASX - By Stock
|
PTX |
Re:
COVID-19
|
|
AMS71
|
62 |
28K |
12 |
22/11/20 |
22/11/20 |
ASX - By Stock
|
62
|
28K
|
12
|
|
ASX - By Stock
|
PTX |
Live Investor briefing 11am today
|
|
AMS71
|
55 |
18K |
4 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
55
|
18K
|
4
|
|
ASX - By Stock
|
PTX |
Interview with Dr Allen Ebens
|
|
AMS71
|
2 |
1.4K |
16 |
09/11/20 |
09/11/20 |
ASX - By Stock
|
2
|
1.4K
|
16
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Extension of Share Purchase Plan
|
|
AMS71
|
45 |
12K |
11 |
15/08/20 |
15/08/20 |
ASX - By Stock
|
45
|
12K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-100 progresses to next cohort in basket clinical study
|
|
AMS71
|
17 |
5.7K |
10 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
17
|
5.7K
|
10
|
|
ASX - By Stock
|
PTX |
Re:
Ann: 2 PTX Assets Chosen in Doherty Institute COVID-19 Program
|
|
AMS71
|
107 |
35K |
8 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
107
|
35K
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Ann: June 2020 Quarterly Update and Appendix 4C
|
|
AMS71
|
36 |
9.6K |
3 |
22/07/20 |
22/07/20 |
ASX - By Stock
|
36
|
9.6K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
Ann: 2 PTX Assets Chosen in Doherty Institute COVID-19 Program
|
|
AMS71
|
107 |
35K |
10 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
107
|
35K
|
10
|
|
ASX - By Stock
|
PTX |
H.C.WAINWRIGHT&CO Broker report
|
|
AMS71
|
10 |
4.3K |
14 |
29/06/20 |
29/06/20 |
ASX - By Stock
|
10
|
4.3K
|
14
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX signs next-gen anti-cancer platform from Penn & Oxford
|
|
AMS71
|
102 |
34K |
9 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
102
|
34K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Prescient Gains IP Rights in CAR-T Collaboration
|
|
AMS71
|
33 |
10K |
6 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
33
|
10K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
AMS71
|
345 |
954K |
4 |
05/03/20 |
05/03/20 |
ASX - By Stock
|
345
|
954K
|
4
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
AMS71
|
345 |
954K |
6 |
30/12/19 |
30/12/19 |
ASX - By Stock
|
345
|
954K
|
6
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 High Overall Response in Ph2a Breast Cancer trial
|
|
AMS71
|
345 |
954K |
22 |
29/12/19 |
29/12/19 |
ASX - By Stock
|
345
|
954K
|
22
|
|
ASX - By Stock
|
PTX Education |
Re:
20 bagger thread
|
|
AMS71
|
318 |
187K |
14 |
25/11/19 |
25/11/19 |
ASX - By Stock
|
318
|
187K
|
14
|
|
ASX - By Stock
|
PTX |
Re:
Ann: AGM Presentation
|
|
AMS71
|
37 |
17K |
7 |
19/11/19 |
19/11/19 |
ASX - By Stock
|
37
|
17K
|
7
|
|
ASX - By Stock
|
PTX |
Re:
Thoughts
|
|
AMS71
|
445 |
210K |
11 |
24/10/19 |
24/10/19 |
ASX - By Stock
|
445
|
210K
|
11
|
|
ASX - By Stock
|
PTX |
Re:
PTX 100 Ras Pathway
|
|
AMS71
|
2 |
1.3K |
9 |
04/06/19 |
04/06/19 |
ASX - By Stock
|
2
|
1.3K
|
9
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Ceasing to be a substantial holder
|
|
AMS71
|
9 |
3.5K |
3 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
9
|
3.5K
|
3
|
|
ASX - By Stock
|
PTX |
Re:
There’s another tech sector Australia is still holding out on...
|
|
AMS71
|
1 |
976 |
6 |
26/03/19 |
26/03/19 |
ASX - By Stock
|
1
|
976
|
6
|
|
ASX - By Stock
|
PTX |
Re:
new broker report on website
|
|
AMS71
|
3 |
1.5K |
2 |
24/03/19 |
24/03/19 |
ASX - By Stock
|
3
|
1.5K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Change of Director's Interest Notice
|
|
AMS71
|
10 |
5.5K |
4 |
19/12/18 |
19/12/18 |
ASX - By Stock
|
10
|
5.5K
|
4
|
|
ASX - By Stock
|
PTX |
Good news from San Antonio
|
|
AMS71
|
0 |
614 |
13 |
17/12/18 |
17/12/18 |
ASX - By Stock
|
0
|
614
|
13
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Interim Durability Analysis of PTX-200 Breast Cancer Study
|
|
AMS71
|
61 |
23K |
1 |
11/12/18 |
11/12/18 |
ASX - By Stock
|
61
|
23K
|
1
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Interim Durability Analysis of PTX-200 Breast Cancer Study
|
|
AMS71
|
61 |
23K |
0 |
10/12/18 |
10/12/18 |
ASX - By Stock
|
61
|
23K
|
0
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Interim Durability Analysis of PTX-200 Breast Cancer Study
|
|
AMS71
|
61 |
23K |
2 |
10/12/18 |
10/12/18 |
ASX - By Stock
|
61
|
23K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: Change of Director's Interest Notices x3
|
|
AMS71
|
3 |
2.3K |
2 |
09/11/18 |
09/11/18 |
ASX - By Stock
|
3
|
2.3K
|
2
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX Appoints Former Array BioPharma Executive to Key Role
|
|
AMS71
|
11 |
4.0K |
8 |
06/11/18 |
06/11/18 |
ASX - By Stock
|
11
|
4.0K
|
8
|
|
Charts
|
SAS |
Re:
SAS Chart
|
|
AMS71
|
673 |
298K |
6 |
25/10/18 |
25/10/18 |
Charts
|
673
|
298K
|
6
|
|
ASX - By Stock
|
PTX |
Notable mention by *
|
|
AMS71
|
13 |
5.6K |
7 |
08/10/18 |
08/10/18 |
ASX - By Stock
|
13
|
5.6K
|
7
|
|
ASX - By Stock
|
PTX |
SYC with PTX100 team
|
|
AMS71
|
0 |
672 |
8 |
20/09/18 |
20/09/18 |
ASX - By Stock
|
0
|
672
|
8
|
|
ASX - By Stock
|
PTX |
Re:
Ann: PTX-200 AML Study Expanded
|
|
AMS71
|
21 |
8.5K |
8 |
30/08/18 |
30/08/18 |
ASX - By Stock
|
21
|
8.5K
|
8
|
|